Samsung Pharm Co Ltd
KRX:001360
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Samsung Pharm Co Ltd (001360) under the Base Case is KRW per share. Compared with the current market price of 1 238 KRW, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Samsung Pharm Does
Samsung Pharm Co Ltd is a South Korean pharmaceutical company that makes and sells medicines and health-related products. Its line-up includes prescription drugs, over-the-counter remedies, and consumer health items that are sold through pharmacies, hospitals, clinics, and other distributors. The company’s business is straightforward: it develops or sources products, manufactures them, and sells them under its own brands.
- Headquarters
- Korea KR
- Employees
- 83
- IPO date
- Jul 4, 1975
Continue Research
Decided on Samsung Pharm? Get an email when Samsung Pharm Co Ltd reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Samsung Pharm Co Ltd stock?
The intrinsic value for Samsung Pharm Co Ltd (001360) under the Base Case is KRW.
Is Samsung Pharm Co Ltd stock undervalued or overvalued?
Compared with the current market price of 1 238 KRW, the stock appears .